186 related articles for article (PubMed ID: 29158796)
1. Radiotherapy Alone or Concurrent Chemoradiation for Esophageal Squamous Cell Carcinoma in Elderly Patients.
Zhao L; Zhou Y; Pan H; Yin Y; Chai G; Mu Y; Xiao F; Lin SH; Shi M
J Cancer; 2017; 8(16):3242-3250. PubMed ID: 29158796
[No Abstract] [Full Text] [Related]
2. Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT.
Xiang G; Xu C; Chai G; Lyu B; Li Z; Wang B; Shi M; Zhao L
Radiat Oncol; 2023 Jul; 18(1):114. PubMed ID: 37430276
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Prognostic Analysis of 315 Stage I-IVa Esophageal Cancer Patients Treated with Simultaneous Integrated Boost-Intensity-Modulated Radiation Therapy.
Cai P; Yang Y; Li DJ
Cancer Manag Res; 2021; 13():6969-6975. PubMed ID: 34522139
[TBL] [Abstract][Full Text] [Related]
4. [Long-term efficacy and safety of simultaneous integrated boost radiotherapy in non-operative esophageal squamous cell carcinoma: a multicenter retrospective data analysis (3JECROG R-05)].
Wang XM; Wang L; Wang X; Chen JQ; Li C; Zhang WC; Ge XL; Shen WB; Hu MM; Yuan QQ; Xu YG; Hao CL; Zhou ZG; Qie S; Lu N; Han C; Pang QS; Wang P; Sun XC; Zhang KX; Li GF; Li L; Liu ML; Wang YD; Qiao XY; Zhu SC; Zhou ZM; Zhao YD; Xiao ZF
Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):889-896. PubMed ID: 34407597
[No Abstract] [Full Text] [Related]
5. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
[TBL] [Abstract][Full Text] [Related]
6. Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancer.
Zhao L; Zhou Y; Mu Y; Chai G; Xiao F; Tan L; Lin SH; Shi M
Oncotarget; 2017 Mar; 8(13):21852-21860. PubMed ID: 28423530
[TBL] [Abstract][Full Text] [Related]
7. Is there a benefit in receiving concurrent chemoradiotherapy for elderly patients with inoperable thoracic esophageal squamous cell carcinoma?
Zhang P; Xi M; Zhao L; Shen JX; Li QQ; He LR; Liu SL; Liu MZ
PLoS One; 2014; 9(8):e105270. PubMed ID: 25133495
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the prognostic factors of simultaneous integrated boost-intensity modulated radiation therapy (SIB-IMRT) in 220 cases of locally advanced squamous esophageal cancer: a retrospective cohort study.
Zhou S; Yang Y; Zhang Q; Zhu C; Cai P; Li D
Ann Transl Med; 2023 Jan; 11(2):103. PubMed ID: 36819557
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of simultaneous integrated boost intensity-modulated radiation therapy for esophageal squamous cell carcinoma in Chinese population: A single institution experience.
Xu Y; Wang Z; Liu G; Zheng X; Wang Y; Feng W; Lai X; Zhou X; Li P; Ma H; Wang J; Hu X; Chen M
J Cancer Res Ther; 2016 Oct; 12(Supplement):82-88. PubMed ID: 27721262
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: Experience of two centers.
Chen F; Luo H; Xing L; Liang N; Xie J; Zhang J
Thorac Cancer; 2018 Jan; 9(1):59-65. PubMed ID: 29024498
[TBL] [Abstract][Full Text] [Related]
11. Clinical Effect of Radiotherapy Combined with Chemotherapy for Non-Surgical Treatment of the Esophageal Squamous Cell Carcinoma.
Chen H; Zhou L; Yang Y; Yang L; Chen L
Med Sci Monit; 2018 Jun; 24():4183-4191. PubMed ID: 29915168
[TBL] [Abstract][Full Text] [Related]
12. Late Toxicities, Failure Patterns, Local Tumor Control, and Survival of Esophageal Squamous Cell Carcinoma Patients After Chemoradiotherapy With a Simultaneous Integrated Boost: A 5-Year Phase II Study.
Chen C; Chen J; Luo T; Wang S; Guo H; Zeng C; Wu Y; Liu W; Huang R; Zhai T; Chen Z; Li D
Front Oncol; 2021; 11():738936. PubMed ID: 34868933
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Clinical Outcomes and Safety Analysis of Superficial Esophageal Cancer Patients Treated with Definitive or Adjuvant Radiotherapy.
Lyu B; Yin Y; Zhao Y; Yang X; Gong J; Zhang M; Chai G; Li Z; Shi M; Hui Z; Zhao L
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884483
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
Wei Z; Zhang Z; Luo J; Li N; Peng X
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
[TBL] [Abstract][Full Text] [Related]
15. [A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy
Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer].
You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):28-34. PubMed ID: 28103970
[TBL] [Abstract][Full Text] [Related]
16. Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial.
Welsh JW; Seyedin SN; Allen PK; Hofstetter WL; Ajani JA; Chang JY; Gomez DR; Amini A; Swisher SG; Blum MA; Younes AI; Nguyen QN; Minsky BD; Erasmus JJ; Lee JH; Bhutani M; Komaki RU
J Thorac Oncol; 2017 Feb; 12(2):375-382. PubMed ID: 27794500
[TBL] [Abstract][Full Text] [Related]
17. [The efficacy and safety of high dose versus standard dose radiotherapy in concurrent chemoradiotherapy for patients with esophageal squamous cell carcinoma].
Ren XJ; Wang L; Han C; Liu LL
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):135-139. PubMed ID: 30862144
[No Abstract] [Full Text] [Related]
18. Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-thoracic/Cervical Esophageal Squamous Cell Carcinomas.
Cheng N; Liu Y; Zhao G; Xu Y; Zhang T; Chen Y; Yan G; Hu Y; Yao S; Wang Z; Wang C; Chen Z; Hu Z; Liu D; Chen T
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):340-348. PubMed ID: 31655197
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of Intensity Modulated Radiation Therapy with Simultaneous Integrated Boost (IMRT-SIB) in head and neck squamous cell carcinoma in patients not suitable for chemo-radiotherapy.
Rastogi M; Sapru S; Gupta P; Gandhi AK; Mishra SP; Srivastava AK; Khurana R; Hadi R; Sahni K; S F
Oral Oncol; 2017 Apr; 67():10-16. PubMed ID: 28351562
[TBL] [Abstract][Full Text] [Related]
20. Age plays an important role in the decision of definitive concurrent chemoradiotherapy (CCRT) for esophageal squamous cell carcinoma (ESCC): a propensity-score matched analysis of multicenter data (3JECROG R-02A).
Wang L; Wang X; Ren X; Han C; Xiao Z; Zhu S; Qiao X; Zhou Z; Shen W; Chen J; Pang Q; Zhang W; Zhao Y; Wang X; Sun X; Ge X; Zhang K; Hu M; Li G; Liu M; Wang Y
Transl Cancer Res; 2021 Jun; 10(6):2932-2943. PubMed ID: 35116602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]